This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
Conditions
- Herpes Zoster Ophthalmicus
Intervention
- Masked Placebo
- Masked Oral Valacyclovir
Principal Investigator
- Hwang, Frank
Sponsor
- New York University School of Medicine
*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 05/01/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.
Request Information
Complete the form below to contact the study team and receive more information about this trial.